Panbela Therapeutics Regains Compliance with Nasdaq Standards

Panbela Therapeutics (PBLA) has released an update.

Panbela Therapeutics, Inc. has announced its return to compliance with Nasdaq’s listing requirements regarding bid price and the number of publicly held shares. This milestone is critical for the company’s continued presence on the stock market, ensuring its shares meet the necessary standards for trading and ownership distribution.

For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.